Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Subklewe

Showing results (71-80 of 244) with videos related to

Pageof 25
Sort By:
Cancers|June 2, 2021
CAR T-Cells for CNS Lymphoma: Driving into New Terrain?Philipp Karschnia, Jens Blobner, Nico Teske, et al.
Transplantation|December 1, 2017
End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD RegistryHeiner Zimmermann, Timm Denecke, Martin H Dreyling, et al.
Transplant Immunology|March 3, 2007
Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTDKathrin Sebelin-Wulf, Tuan D Nguyen, Stephan Oertel, et al.
Haematologica|April 6, 2019
Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-inductionThomas Köhnke, Veit Bücklein, Sandra Rechkemmer, et al.
NPJ Precision Oncology|January 25, 2025
Adding checkpoint inhibitors to first-line chemotherapy for NUT carcinoma patientsSarah Haebe, Gesa Schuebbe, Philipp Jurmeister, et al.
Infection|May 27, 2025
Clinical features, course, and risk factors of infection-associated secondary hemophagocytic lymphohistiocytosisMichael Ruzicka, Thomas Wimmer, Hans-Joachim Stemmler, et al.
Journal for Immunotherapy of Cancer|June 17, 2018
Cytokine release syndromeAlexander Shimabukuro-Vornhagen, Philipp Gödel, Marion Subklewe, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafetyMarkus H Hammer, Gordon Brestrich, Alexa Mittenzweig, et al.
Bone Marrow Transplantation|April 16, 2024
Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicityEmily C Liang, Kai Rejeski, Teng Fei, et al.
Bone Marrow Transplantation|November 12, 2024
Correction: Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicityEmily C Liang, Kai Rejeski, Teng Fei, et al.
Pageof 25

Showing results (71-80 of 244) with videos related to

Sort By:
Pageof 25
Cancers|June 2, 2021
CAR T-Cells for CNS Lymphoma: Driving into New Terrain?Philipp Karschnia, Jens Blobner, Nico Teske, et al.
Transplantation|December 1, 2017
End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD RegistryHeiner Zimmermann, Timm Denecke, Martin H Dreyling, et al.
Transplant Immunology|March 3, 2007
Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTDKathrin Sebelin-Wulf, Tuan D Nguyen, Stephan Oertel, et al.
Haematologica|April 6, 2019
Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-inductionThomas Köhnke, Veit Bücklein, Sandra Rechkemmer, et al.
NPJ Precision Oncology|January 25, 2025
Adding checkpoint inhibitors to first-line chemotherapy for NUT carcinoma patientsSarah Haebe, Gesa Schuebbe, Philipp Jurmeister, et al.
Infection|May 27, 2025
Clinical features, course, and risk factors of infection-associated secondary hemophagocytic lymphohistiocytosisMichael Ruzicka, Thomas Wimmer, Hans-Joachim Stemmler, et al.
Journal for Immunotherapy of Cancer|June 17, 2018
Cytokine release syndromeAlexander Shimabukuro-Vornhagen, Philipp Gödel, Marion Subklewe, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 1, 2007
Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafetyMarkus H Hammer, Gordon Brestrich, Alexa Mittenzweig, et al.
Bone Marrow Transplantation|April 16, 2024
Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicityEmily C Liang, Kai Rejeski, Teng Fei, et al.
Bone Marrow Transplantation|November 12, 2024
Correction: Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicityEmily C Liang, Kai Rejeski, Teng Fei, et al.
Pageof 25